EMBL

Data from AbbVie and Johnson & Johnson will fine-tune OpenFold3 in a confidentiality-preserving environment, powered by Apheris.

Biotech company Immunai, which developed an AI-based immune system mapping technology for drug development, announces the appointment of Dr. Mikael Dolsten to its board of directors.

This review discusses the current state of multicancer early detection tests, the role of machine learning in their development, and their implications for oncology practice and patient care.

Coordinated by BSC and supported by EuroHPC and the Spanish Ministry of Science, Innovation and Universities, DARE brings together 38 leading European partners to reduce Europe's dependence on foreign

The arrival of big data, artificial intelligence (AI), and shared databases, offers unparallelled potential for advancing the study and treatment of rare diseases

The National Synchrotron Light Source II (NSLS-II)—a U.S. Department of Energy (DOE) Office of Science user facility at DOE's Brookhaven National Laboratory—is among the world's most advanced synchrotron light sources,

Iktos, a global leader in AI-driven drug discovery, has secured a prestigious €2.5 million grant from the European Innovation Council (EIC) Accelerator to advance its AI and robotics synthesis automation technology.

Enzymes significantly speed up the chemical reactions that keep you alive. Researchers are using AI to create new ones to tackle modern challenges.